SCHEMBL2949324

SCHEMBL2949324

CCOC(=O)c1ccc(-c2ccc(-c3nc(-c4cc(OC)ccc4OC)co3)cc2)cc1

nearest known ligand 0.48

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
TARBP2 Q15633 2/20 0.48
PDCD4 Q53EL6 1/20 0.48
PDGFRB P09619 1/20 0.47
PDGFRA P16234 1/20 0.47
MAPT P10636 7/20 0.46
KMT2A Q03164 3/20 0.46
MEN1 O00255 2/20 0.46
GAA P10253 1/20 0.46
HTT P42858 2/20 0.45
ENPP3 O14638 1/20 0.45
ENPP1 P22413 1/20 0.45
ALDH1A1 P00352 2/20 0.44
TDP1 Q9NUW8 1/20 0.44
HSD17B10 Q99714 2/20 0.44
KDM4E B2RXH2 1/20 0.44
HPGD P15428 1/20 0.44
LMNA P02545 1/20 0.43
TP53 P04637 1/20 0.43
USP2 O75604 2/20 0.43
L3MBTL1 Q9Y468 2/20 0.42

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL2942196 0.86 ENPP3 (0.52) MAPTENPP3ENPP1ALDH1A1HSD17B10
SCHEMBL2949886 0.78 KMT2A (0.54) TARBP2MAPTKMT2AMEN1GAA
SCHEMBL2952406 0.78 ENPP3 (0.51) MAPTKMT2AMEN1ENPP3ENPP1
SCHEMBL12171862 0.76 STIM1 (0.50) MAPTENPP3ENPP1ALDH1A1KDM4E
SCHEMBL7217126 0.76 ENPP3 (0.54) TARBP2MAPTKMT2AMEN1GAA
SCHEMBL7215537 0.74 TARBP2 (0.55) TARBP2MAPTKMT2AMEN1ALDH1A1
SCHEMBL8800860 0.74 MAPT (0.54) PDGFRBPDGFRAMAPTKMT2AMEN1
SCHEMBL2997359 0.73 MAPT (0.59) TARBP2PDCD4MAPTKMT2AMEN1
SCHEMBL16378629 0.73 ENPP3 (0.64) MAPTKMT2AMEN1ENPP3ENPP1
SCHEMBL17055727 0.73 HDAC1 (0.64) TARBP2PDCD4MAPTGAAHTT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 8 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-7754886-B2 N-acylsulfonamide apoptosis promoters ABBOTT LABORATORIES (US) 2010-07-13 US disclosed
US-20090137585-A1 N-ACYLSULFONAMIDE APOPTOSIS PROMOTERS ABBOTT LABORATORIES (US) 2009-05-28 US disclosed
US-7504512-B2 N-acylsulfonamide apoptosis promoters ABBOTT LABORATORIES (US) 2009-03-17 US disclosed
EP-1318978-B1 N-ACYLSULFONAMIDE APOPTOSIS PROMOTERS ABBOTT LAB (US) 2006-02-08 EP disclosed
US-20040192681-A1 N-acylsulfonamide apoptosis promoters ABBVIE INC. 2004-09-30 US disclosed
US-6720338-B2 BCL-X1 INHIBITING COMPOSITIONS AND METHODS OF PROMOTING APOPTOSIS IN A MAMMAL ABBOTT LABORATORIES 2004-04-13 US disclosed
US-20020086887-A1 N-Acylsulfonamide apoptosis promoters ABBVIE INC. 2002-07-04 US disclosed
US-20020055631-A1 N-acylsulfonamide apoptosis promoters ABBOTT LABORATORIES 2002-05-09 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (4 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20020086887-A1 N-Acylsulfonamide apoptosis promoters BAX, BCLAF1, BCL2 TARBP2 3686/4885PDCD4 1073/4885PDGFRB 3556/4885
US-20020055631-A1 N-acylsulfonamide apoptosis promoters BAX, BCLAF1, BCL2 TARBP2 3624/4885PDCD4 1140/4885PDGFRB 2874/4885
US-20040192681-A1 N-acylsulfonamide apoptosis promoters BAX, BCLAF1, BCL2 TARBP2 3686/4885PDCD4 1073/4885PDGFRB 3556/4885
US-20090137585-A1 N-ACYLSULFONAMIDE APOPTOSIS PROMOTERS BAX, BCL2, BCOR TARBP2 3376/4885PDCD4 892/4885PDGFRB 2177/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.